HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies. [electronic resource]
Producer: 20180129Description: 257-73 p. digitalISSN:- 1573-7209
- Angiogenesis Inducing Agents -- administration & dosage
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Anthracyclines -- therapeutic use
- Biphenyl Compounds -- therapeutic use
- Cardiac Glycosides -- therapeutic use
- Humans
- Hypoxia-Inducible Factor 1 -- antagonists & inhibitors
- Indazoles -- therapeutic use
- Lignans -- therapeutic use
- Models, Biological
- Neoplasms -- blood supply
- Neovascularization, Pathologic -- drug therapy
- Retinal Neovascularization -- drug therapy
- Vascular Endothelial Growth Factors -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.